Imunocare

Imiquimod, the active ingredient in Imunocare, is a immune response modifier presented as a topical formulation for skin application. It is used to treat precancerous and viral skin lesions by stimulating local immune activity in patients with actinic keratosis, superficial basal cell carcinoma, or external genital warts.

GNH USA supplies Imunocare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imunocare is a topical immunomodulator that acts on skin lesions associated with viral infection or early skin cancer. - Actinic keratosis: reduces lesion size and prevents progression to squamous cell carcinoma. - Superficial basal cell carcinoma: promotes clearance of tumor cells through local immune activation. - External genital warts: eliminates wart tissue by enhancing antiviral immune responses.

Imunocare may cause a range of local and systemic reactions.

Common Side Effects: - Redness or erythema at the application site. - Itching or pruritus. - Burning or stinging sensation. - Scaling or flaking of the skin. - Dryness of the treated area.

Serious or Rare Side Effects: - Severe allergic reaction, including angioedema. - Extensive ulceration or necrosis of the skin. - Systemic flu‑like symptoms such as fever and malaise. - Secondary bacterial infection of the treated lesion.

Before using Imunocare, consider the following safety measures. - Pregnancy: safety not established; avoid use unless benefits outweigh risks. - Breastfeeding: unknown safety; consider potential exposure to infant. - Immunocompromised patients: monitor closely as response may be altered. - Apply only to diagnosed lesions; do not treat healthy skin. - Avoid concurrent use of other irritating topicals or chemical peels. - Store at room temperature: keep in the original container, protect from moisture and light.

Imunocare can interact with other topical or systemic agents.

Major Interactions (Avoid): - Concurrent use with other immune‑modulating topicals may increase local irritation. - Systemic immunosuppressants could reduce the efficacy of Imiquimod.

Moderate Interactions (Monitor Closely): - Topical corticosteroids applied to the same area may diminish therapeutic effect. - Phototherapy or UV exposure can heighten skin sensitivity. - Herbal or over‑the‑counter skin preparations may add to irritation risk.